ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Schwab Emerging Markets Equity

Schwab Emerging Markets Equity (SCHE)

26.67
-0.08
(-0.30%)
Closed June 22 3:00PM
26.50
-0.17
(-0.64%)
After Hours: 6:58PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
26.50
Bid
-
Ask
-
Volume
594,386
26.67 Day's Range 26.7783
22.8838 52 Week Range 27.2289
Market Cap
Previous Close
26.75
Open
26.74
Last Trade
23352
@
26.67
Last Trade Time
Financial Volume
US$ 15,874,160
VWAP
26.7068
Average Volume (3m)
865,387
Shares Outstanding
343,700,000
Dividend Yield
-
PE Ratio
150.56
Earnings Per Share (EPS)
0.18
Revenue
269.98M
Net Profit
60.89M

About Schwab Emerging Markets Equity

The funds goal is to track as closely as possible before fees and expenses the total return of the FTSE Emerging Index. The fund will invest at least 90% of its net assets (including, for this purpose, any borrowings for investment purposes) in these stocks, including depositary receipts representin... The funds goal is to track as closely as possible before fees and expenses the total return of the FTSE Emerging Index. The fund will invest at least 90% of its net assets (including, for this purpose, any borrowings for investment purposes) in these stocks, including depositary receipts representing securities of the index; such depositary receipts may be in the form of ADRs, GDRs and EDRs. It generally invests in stocks that are included in the FTSE Emerging Index. The index is comprised of large and mid capitalization companies in emerging market countries, as defined by the index provider. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Headquarters
San Francisco, California, USA
Founded
1970
Schwab Emerging Markets Equity is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker SCHE. The last closing price for Schwab Emerging Markets ... was US$26.75. Over the last year, Schwab Emerging Markets ... shares have traded in a share price range of US$ 22.8838 to US$ 27.2289.

Schwab Emerging Markets ... currently has 343,700,000 shares outstanding. The market capitalization of Schwab Emerging Markets ... is US$9.17 billion. Schwab Emerging Markets ... has a price to earnings ratio (PE ratio) of 150.56.

SCHE Latest News

No news to show yet.
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10.130.49298445202926.3726.895426.34570845626.67108684SP
4-0.26-0.97159940209326.7626.895425.76571643326.39666133SP
121.134.454079621625.3727.228924.60586538725.91641106SP
262.289.413707679624.2227.228923.33113799224.98192471SP
521.757.0707070707124.7527.228922.8838131060124.57801135SP
156-6.08-18.661755678332.5833.1921.36193415725.89176564SP
2600.220.83713850837126.2834.7418.3201200660225.84987099SP

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LPENLoop Energy Inc
$ 0.045
(80.00%)
87.26k
BNGBengal Energy Ltd
$ 0.04
(33.33%)
113.25k
ESMEuro Sun Mining Inc
$ 0.07
(16.67%)
297.14k
MDNAMedicenna Therapeutics Corp
$ 1.92
(16.36%)
175.01k
FANSFansUnite Entertainment Inc
$ 0.04
(14.29%)
1.29M
VPHValeo Pharma Inc
$ 0.10
(-28.57%)
96.5k
SAMStarcore International Mines Ltd
$ 0.12
(-14.29%)
53.5k
BUBurcon NutraScience Corporation
$ 0.21
(-10.64%)
46.26k
DYADynaCERT Inc
$ 0.135
(-10.00%)
328.55k
GECGlobal Education Communities Corp
$ 0.325
(-9.72%)
17k
CVECenovus Energy Inc
$ 25.54
(-0.82%)
46.8M
TRPTC Energy Corporation
$ 52.71
(0.94%)
29.7M
CNQCanadian Natural Resources Ltd
$ 47.19
(-1.44%)
22.36M
CXBCalibre Mining Corp
$ 1.80
(-3.23%)
19.95M
TDToronto Dominion Bank
$ 74.00
(0.09%)
16.65M

Discussion

View Full Feed
biowin biowin 5 minutes ago
We need Mohammed bin Salman to bring his billions with KKR to buyout all Bioamber's contacts
https://www.pwc.com/m1/en/media-centre/articles/nurturing-homegrown-innovation-and-investment.html
KKR
Chartmaster Chartmaster 6 minutes ago
Chart shows the potential massive blue sky breakout above 12's here, this could skyrocket! .02min, forget the .10 max, peeps can't seem to wrap their heads around that. SMH

https://investorshub.advfn.com/uimage/uploads/2024/6/22/[vxrkTKMO_6-21-24.PNG
SMH
SSKILLZ1 SSKILLZ1 7 minutes ago
I don't think you would have any chance of winning doing that, but you theoretically could.
Carjockey2 Carjockey2 8 minutes ago
And we all lost or didn't copy our 2022/23 gains, too....

LMAO
SMCE
Hoskuld Hoskuld 9 minutes ago
Sometimes I think you can look at a company and back out the cash and say, "look how little the IP is valued at! what a bargain!" But in reality that cash will ALL be spent (and more) in order to fulfill the company's mission. It is gas in the tank and it doesn't contribute to the value of the bus
BMY
drugrunner drugrunner 9 minutes ago
Depends what they thought they were culturing … besides CDIFF

I was treating organ transplant patients back then so the name of the sepsis drugs back then escapes me at the moment
NWBO
jimr1717 jimr1717 9 minutes ago
Just a heads up, 🏆️ How did $102.000 in inventory disappear with no record? The last report filed shows that existing inventory fell from $120,000 of feed stock to $18,000 in a year ... even though there were only $20,000 of sales in the entire year. So, $102,000 of inventory disappeared wit
IFUS
Myth Myth 10 minutes ago
you just made my day Okie, so glad to hear from you.

We're always thinking of you friend..

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174011074&txt2find=okie
m_m007 m_m007 11 minutes ago
This won’t see below 0035 again. The dip is not here. People that sold on. Friday are crazy. That’s where you buy. X is hoooooottt on $SMCE. This weekend tells me that Monday we gap
SMCE
MG08 MG08 12 minutes ago
There are 5 reasons any dip in Nvidia stock will be short-lived - and investors should use a decline as a buying opportunity
Matthew Fox Jun 20, 2024, 1:51 PM EDT

https://markets.businessinsider.com/news/stocks/nvidia-stock-price-prediction-buy-nvda-decline-dot-com-differences-
NVDA
JohnnyBlaze JohnnyBlaze 12 minutes ago
Looked like some light loading
NHYF
drugrunner drugrunner 12 minutes ago
Neither is cost prohibitive …

My brother in law passed away in 2003 on H1N1 before we knew what it was ..
Died within 4 days of symptom onset ..

Hospital started him on fluids
No empiric antibiotic treatment !!!

They gave him 16 liters o
NWBO
JohnnyBlaze JohnnyBlaze 13 minutes ago
Sick, I’m going to be a multi millionaire
AFFL
JohnnyBlaze JohnnyBlaze 13 minutes ago
Base is in
BFCH
StayHumble StayHumble 14 minutes ago
SECAlert:Kramer&AssMgmtLLC | UnregisteredSolicitingEntities (PAUSE)
The PAUSE Program lists entities that falsely claim to be registered, licensed, and/or located in the United States in their solicitation of investors.

The PAUSE Program also lists entities that impersonat
DBMM GTII HPIL
rbl100 rbl100 14 minutes ago
Just wait till the lockdown files are public. They all knew there was never a "pandemic" instead it was a plandemic of the largest fraud and hoax on humanity.
Remember how every insert of every vile of covid death shots were BLANK ? Now pfizer posts on their own website all of the "side effec
DJT
cableguy cableguy 14 minutes ago
Well luck nuclear will take a lot longer to perfect, so I believe we are golden here with RONN
RONN
UpTickMeA$AP UpTickMeA$AP 14 minutes ago
https://youtu.be/4Vv5CsP1pAg?feature=shared
COOP
Cabinmoney Cabinmoney 14 minutes ago
No im not that smart. But I am smart enough to NOT make a wrong prediction EVERY quarter. And that IS smarter than you.
RXMD
rbl100 rbl100 15 minutes ago
They didn't. These events started in 2021. Did you interview pathologists and coroners? .We are not talking car accidents or drug overdoses. You know full well the difference.
DJT
Whalatane Whalatane 15 minutes ago
Hi North No I don't think theres a generic called Vascepa or Vazkepa .
The article Capt linked ...when discussing CV meds mentioned IPE ...didnt differentiate brand Vascepa from the generic IPE for the CV indication in the US .
Any prescriber reading that in the US thinks OK, IPE
AMRN
JamesLH JamesLH 16 minutes ago
Hey Ricki, how are those "paid bashers" treating you?? LMFAO

Only a low IQ Muppet like you thinks anyone would actually "pay" to bash a scam like SNPW. LMFAO
SNPW
vegasopc vegasopc 17 minutes ago
A steal at this price...hmmmmmmmmmmm
FSRNQ

Your Recent History

Delayed Upgrade Clock